Advertisement

Tardive dyskinesia: Questions when changing medications

Questions to discuss with your healthcare provider when changing or adding medications to treat tardive dyskinesia.

An older man reads a medication label at home at his kitchen table, while looking up information on a tablet.

Updated on December 9, 2024

Tardive dyskinesia is a condition that causes involuntary movements. These can include movements that affect the face, such as chewing motions, excessive blinking, sticking out the tongue, and frowning. It can also include movements that affect other parts of the body—TD can cause a person to involuntary tap their feet, wiggle their fingers, and move their arms, legs, torso, or neck.

What causes tardive dyskinesia?

TD occurs as a side effect of medications called neuroleptics. Also known as antipsychotic medications, neuroleptics are drugs that act on the brain. More specifically, neuroleptics act on neurotransmitters. Neurotransmitters are substances released by nerve cells that send a signal to other nerve cells. They are sometimes described as “chemical messengers.”

A fairly well-known neurotransmitter is dopamine. Dopamine is released in response to experiences that are pleasurable or rewarding (though it plays a role in many different functions). Most neuroleptic medications act on dopamine receptors in the brain (though newer medications work through other mechanisms).

Neuroleptic medications are used in the treatment and management of psychiatric conditions. These medications are the main treatment for schizophrenia, a mental health condition that causes psychosis. Psychosis is a collection of symptoms that occur when the mind loses contact with reality, affecting a person’s ability to distinguish what is real and what is not.

Neuroleptics are also prescribed in the treatment of bipolar disorder, major depression, and other psychiatric conditions.

Can non-neuroleptic medications cause tardive dyskinesia?

In addition to neuroleptics, TD can be caused by certain other medications. This includes anti-seizure medications, anti-Parkinson medications, antidepressants, and some medications used to treat a stomach disorder called gastroparesis.

Questions when starting or changing a medication

Most people with TD will be living with schizophrenia or another psychiatric condition, and they will need to continue to manage that condition with neuroleptic medications.

Treatment for TD can involve changing the type of neuroleptic a person is taking, changing the dosage, and/or taking additional medications that help reduce and control symptoms of TD. Changes to medications must always be made under the guidance of a healthcare provider.

People with TD and associated conditions are also encouraged to take an active role in their healthcare and treatment decisions. With that in mind, the following list of questions can be helpful when changing medications or starting a new medication:

  • What is the name of the medication I am being prescribed?
  • What dosage am I being prescribed?
  • How does this medication work? What are the goals of taking this medication?
  • How is the medication taken and how often will I need to take it?
  • How will we know if the medication is working? What happens if this medication does not work?
  • What are the potential side effects of taking this medication? Is there a risk of serious side effects?
  • How can I expect to feel when taking this medication?
  • Is there anything I need to avoid while taking this medication?
  • Who can I talk to if I have concerns about the cost of this medication
  • Can this medication interact with other medications I am currently taking? Keep a list of all medications you take, including prescriptions, over-the-counter medications, and supplements (including herbal supplements).
Article sources open article sources

National Alliance on Mental Illness. Tardive Dyskinesia.
MedlinePlus. Tardive dyskinesia.
Carol Tamminga. Antipsychotic Drugs. Merck Manual Consumer Version. April 2022.
Mohor Sengupta. What Is a Neurotransmitter? Biomedical Beat Blog – National Institute of General Medical Sciences. August 29, 2024.
Stephanie Watson. Dopamine: The pathway to pleasure. Harvard Health Publishing. April 18, 2024.
Muhammad Atif Ameer, Preeti Patel, and Abdolreza Saadabadi. Neuroleptic Medications. StatPearls. February 21, 2024.
Cleveland Clinic. Antipsychotic Medications.
Inder Kaul, Sharon Sawchak, et al. Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials. Schizophrenia, 2024. Vol. 10.
National Institute of Mental Health. Schizophrenia.
National Institute of Mental Health. Understanding Psychosis.
Sarayu Vasan and Ranjit K. Padhy. Tardive Dyskinesia. StatPearls. April 24, 2023.
National Organization for Rare Disorders. Tardive Dyskinesia.
Jose I. Perez-Revuelta, Francisco Gonzalez-Saiz, et al. Shared decision making with schizophrenic patients: a randomized controlled clinical trial with booster sessions (DECIDE Study). Patient Education and Counseling, 2023. Vol. 110.
MedlinePlus. Taking medicines - what to ask your provider.
National Institute of Mental Health. Mental Health Medications.

Featured Content

article

Are there medications that treat tardive dyskinesia?

Learn about medications called VMAT2 inhibitors, which can help control the symptoms of tardive dyskinesia.
article

Describing the emotional impact of TD

Learn how the impact of this involuntary movement disorder extends beyond physical symptoms.
video

5 ways to support someone with tardive dyskinesia

Here are five strategies you can use to support someone with TD.
article

Tardive dyskinesia: Examples of involuntary movements

A look at some common examples of involuntary, repetitive movements that occur with tardive dyskinesia (TD).
video

What does it mean to be a self-advocate with TD?

Being a self-advocate with tardive dyskinesia means communicating what you need and what you desire for treatment.